The interaction between CCL5 and CCR5 can promote the proliferation and metastasis of cancer cells by enhancing protein kinase B (PKB, AKT) and EMT, while inhibition of the interaction between CCL5 and CCR5 can lead to apoptosis of HCC cells [8]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.